A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)
Clinical trial NCT07748403 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07748403
- Sponsor
- Prime Medicine, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-11-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.